PHARM — Pharming NV Balance Sheet
0.000.00%
Last trade - 00:00
- €484.34m
- €449.77m
- $245.32m
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 74.3 | 205 | 192 | 207 | 213 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 28.9 | 31.9 | 27.6 | 25.3 | 42.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 119 | 263 | 249 | 278 | 316 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 16.3 | 21.7 | 33.2 | 39.1 | 33.5 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 256 | 418 | 397 | 426 | 463 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 114 | 76.8 | 46.8 | 59.7 | 78 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 139 | 235 | 204 | 221 | 244 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 117 | 183 | 193 | 205 | 219 |
Total Liabilities & Shareholders' Equity | 256 | 418 | 397 | 426 | 463 |
Total Common Shares Outstanding |